Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients
C Kalani, E Awudi, T Alexander, G Udeani… - Hospital …, 2019 - Taylor & Francis
Purpose: There is limited clinical data evaluating anticoagulation with the direct oral
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …
[引用][C] Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients
C Kalani, E Awudi, T Alexander, G Udeani, S Surani - Hospital Practice, 2019 - cir.nii.ac.jp
Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in
morbidly obese patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
morbidly obese patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients
C Kalani, E Awudi, T Alexander… - Hospital practice …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose: There is limited clinical data evaluating anticoagulation with the direct oral
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …
Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
C Kalani, E Awudi, T Alexander, G Udeani… - Hospital Practice …, 2019 - europepmc.org
Purpose: There is limited clinical data evaluating anticoagulation with the direct oral
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …
anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in …